AIM jab pipeline sparks share rally
August 28, 2025 | 18:25
Analysts double price targets after mRNA flu data—can labs deliver shots before hype cools?
AIM Vaccine's mRNA Shingles Shot Approved in China and the U.S.
May 19, 2025 | 14:31
Breakthrough approval highlights the power of AIM’s next-gen platform and global ambition in biotech innovation.
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
March 24, 2025 | 14:43
AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025.
Mobile Version